Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2020-10, Vol.11, p.595289-595289
Main Authors: De Souza, Andre, Tavora, Fabio A., Mahalingam, Devalingam, Munster, Pamela N., Safran, Howard P., El-Deiry, Wafik S., Carneiro, Benedito A.
Format: Article
Language:English
Subjects:
9-ING-41
COVID
COVID-19
glycogen synthase kinase-3 (GSK-3) inhibitor
glycogen synthase kinase-3 (GSK3)
GSK-3b inhibitor
Immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2020.595289